Site Search

FRANKFORT, KY – Today, the General Assembly passed legislation that will increase access to biomarker testing, which can help determine the best treatment plan for a specific patient. Despite its benefits, private health insurance and Medicaid coverage of biomarker testing have not kept pace with the rate of innovation. This legislation, House Bill 180, fixes that barrier to access for many ...

... Assembly was supporting HCR 35 and SCR 29 which, if adopted, would allow for an auditor study to assess health insurance coverage for biomarker testing for Hawaii residents. Currently, insurance coverage for biomarker testing is failing to keep pace with innovation and advancement in treatment. Progress in improving cancer outcomes increasingly involves ...

... Network (ACS CAN) urges legislators to prioritize legislation that will improve access to care for cancer patients by expanding coverage for biomarker testing. “ACS CAN calls on the legislature to increase access to biomarker testing, an essential step in accessing precision medicine treatments by ensuring state regulated health insurance, including Medicaid, ...

... in the U.S. and is the only state with an increasing rate of cancer. “ACS CAN calls on the legislature to improve coverage of comprehensive biomarker testing, a game changer in the fight against cancer. Progress in improving cancer outcomes increasingly involves the use of precision medicine, which uses information about a person’s own genes or proteins to better diagnose and treat diseases like cancer. Biomarker testing is an important step to accessing precision medicine which includes targeted therapies that can lead to improved survivorship and ...